OpenSecrets.org @OpenSecretsDC
In 2018, INSYS Therapeutics spent $250,000 on lobbying, all of which focused on HR6, the "Using Data To Prevent Opioid Diversion Act of 2018" https://t.co/DJr5M0C3Ic — PolitiTweet.org
Siraj Hashmi @SirajAHashmi
NEW: Opioid drugmaker Insys Therapeutics files for bankruptcy a week after agreeing to pay $225 million to settle a… https://t.co/hVncjElXxS